Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 7. 4. 2020, under the no. SUKLS186613/2017:

• the operative part 1b) of the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 7. 4. 2020, under the no.: SUKLS185422/2017:

• the operative part 1b) of the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Krka, tovarna zdravil, d.d., Novo mesto, against the decision of the State Institute for Drug Control from 10. 6. 2022, under the no: SUKLS115353/2022:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 21. 2. 2020, under the no. SUKLS224290/2019:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Union of Health Insurance Companies, Zentiva, k.s., Xantis Pharma Limited, Adamed Pharma S.A., against the decision of the State Institute for Drug Control from 28. 2. 2020 under the no: SUKLS27614/2017:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 31. 3. 2020, under the no.: SUKLS220471/2019:

• the operative part 2 of the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  
• The rest of the decision under appeal is upheld

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 15. 4. 2020, under the no: SUKLS27746/2020:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Bristol-Myers Squibb Pharma EEIG, against the decision of the State Institute for Drug Control from e 3. 3. 2020, under the no. SUKLS298091/2019:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.